Who Should Get Scarce Lifesaving CoVid Therapy?
13 nov 2020 ·
1 min. 1 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Vidcast: https://youtu.be/Fi_tg8c1pvg With Covid19 skyrocketing, scarce ICU beds and cutting edge therapies are in short supply. How and who will decide which patients get effective treatment? A study from Ohio...
mostra di più
Vidcast: https://youtu.be/Fi_tg8c1pvg With Covid19 skyrocketing, scarce ICU beds and cutting edge therapies are in short supply. How and who will decide which patients get effective treatment? A study from Ohio State and The Chinese University of Hong Kong presents public opinion on the subject. The researchers surveyed 5175 participants in 11 countries asking them which factors should dictate the decision to treat. The two most important were age selected by 26.5% and probability of survival chosen by 23.3%. The other factors in rank order were nationality, criminal record, predicted cost of treatment, expected ventilator days, family, and gender. By wearing masks, distancing, and cleaning, we hope to never have to ration care. https://www.journals.uchicago.edu/doi/pdf/10.1086/711734 #covid #rationing #ethics
mostra meno
Informazioni
Autore | Howard G. Smith MD |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company